The Role of MeCP2 in Brain Development and Neurodevelopmental Disorders
Open Access
- 24 March 2010
- journal article
- review article
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 12 (2) , 127-134
- https://doi.org/10.1007/s11920-010-0097-7
Abstract
Methyl CpG binding protein-2 (MeCP2) is an essential epigenetic regulator in human brain development. Rett syndrome, the primary disorder caused by mutations in the X-linked MECP2 gene, is characterized by a period of cognitive decline and development of hand stereotypies and seizures following an apparently normal early infancy. In addition, MECP2 mutations and duplications are observed in a spectrum of neurodevelopmental disorders, including severe neonatal encephalopathy, X-linked mental retardation, and autism, implicating MeCP2 as an essential regulator of postnatal brain development. In this review, we compare the mutation types and inheritance patterns of the human disorders associated with MECP2. In addition, we summarize the current understanding of MeCP2 as a central epigenetic regulator of activity-dependent synaptic maturation. As MeCP2 occupies a central role in the pathogenesis of multiple neurodevelopmental disorders, continued investigation into MeCP2 function and regulatory pathways may show promise for developing broad-spectrum therapies.Keywords
This publication has 53 references indexed in Scilit:
- Rett Syndrome Astrocytes Are Abnormal and Spread MeCP2 Deficiency through Gap JunctionsJournal of Neuroscience, 2009
- The common BDNF polymorphism may be a modifier of disease severity in Rett syndromeNeurology, 2009
- Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndromeAnnals of Neurology, 2009
- Non–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphologyNature Neuroscience, 2009
- Structural variation in Xq28: MECP2 duplications in 1% of patients with unexplained XLMR and in 2% of male patients with severe encephalopathyEuropean Journal of Human Genetics, 2008
- Methyl‐CpG‐binding protein 2 polymorphisms and vulnerability to autismGenes, Brain and Behavior, 2008
- FOXG1 Is Responsible for the Congenital Variant of Rett SyndromeAmerican Journal of Human Genetics, 2008
- MeCP2, a Key Contributor to Neurological Disease, Activates and Represses TranscriptionScience, 2008
- Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genesProceedings of the National Academy of Sciences, 2007
- Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2Proceedings of the National Academy of Sciences, 2007